Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01498224 · ClinicalTrials.gov registry record · Phase 3
ReSure Sealant Pivotal Study
A Phase 3 study, sponsored by Ocular Therapeutix.
- Completed
- Registry status
- Phase 3
- Development phase
- 488
- Enrollment target
NCT01498224 is a Phase 3 study that has completed, run by Ocular Therapeutix. The registered enrollment target is 488 participants.
The verdict
NCT01498224, a Phase 3 study, has completed, sponsored by Ocular Therapeutix.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 488 participants
- Enrollment target
Study Summary
This is a randomized multicenter study to evaluate the safety and effectiveness of ReSure Sealant compared to sutures for preventing incision leakage within the first 7 days of cataract surgery.
Interventions
- PROCEDURE Sutures
- DEVICE ReSure Sealant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 488 participants |
| Start Date | 2011-12 |
| Est. Completion | 2012-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01498224
The ClinicalTrials.gov registry entry for NCT01498224 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 488 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ocular Therapeutix, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sutures is the first listed.
NCT01498224 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01498224 about?
NCT01498224 is a clinical study titled "ReSure Sealant Pivotal Study". This is a randomized multicenter study to evaluate the safety and effectiveness of ReSure Sealant compared to sutures for preventing incision leakage within the first 7 days of cataract surgery.
What is the current status of trial NCT01498224?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 488 participants. The study started on 2011-12. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01498224?
The interventions under investigation include: Sutures (PROCEDURE), ReSure Sealant (DEVICE).
Who is sponsoring clinical trial NCT01498224?
This trial is sponsored by Ocular Therapeutix, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.